Company / Assets per Share
IOVANCE BIOTHERAPEUTICS, INC. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$2.99
FY2025
5-year range
$2.99 / $5067.16
FY2021-FY2025
Trend
-15.8%
vs FY2024
Sector context
#175 of 210
Health Care
What the data says
IOVANCE BIOTHERAPEUTICS, INC.'s assets per share of $2.99 is lower than 83% of companies in the Health Care sector (FY2025). Assets per Share has declined for 5 consecutive years, from $5556.42 in FY2020 to $2.99 in FY2025.
Based on SEC 10-K filings.
2.99 in FY2025 with a 5-year CAGR of -77.8%.
Declined from $4.15 to $2.99 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -91.0%
- 5-Year CAGR
- -77.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 210This company $2.99 Sector average $296.79
▼
-99.0% below sector average
Key checks
Key Insights
- IOVANCE BIOTHERAPEUTICS, INC.'s assets per share has declined for 5 consecutive years.
- In FY2025, assets per share decreased 15.8% year-over-year.
- Ranks #175 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.99 | -15.8% |
| FY2024 | $3.55 | -14.5% |
| FY2023 | $4.15 | -99.9% |
| FY2022 | $4169.20 | -17.7% |
| FY2021 | $5067.16 | -8.8% |
| FY2020 | $5556.42 | +100.5% |
| FY2019 | $2771.96 | +42080.1% |
| FY2018 | $6.57 | +163.3% |
| FY2017 | $2.50 | -29.5% |
| FY2016 | $3.54 | +13.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026